Abbott issues 'urgent' message to patients after medical devices linked to 700 injuries, 7 deaths

The Food and Drug Administration issued an alert about a “potentially high-risk issue” regarding malfunctioning Abbott glucose sensors that have been linked to more than 700 serious injuries and 7 ...
MedTech Dive

Abbott receives clearance for heart delivery device in premature babies

The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...

Abbott Gets FDA Approval for Volt Medical Device to Treat Arrhythmia

Abbott received approval from the Food and Drug Administration for its Volt Pulsed Field Ablation System to treat atrial fibrillation. The medical technology company said Monday that it would soon ...
Becker's Hospital Review

Abbott, St. Jude Medical will sell devices to Terumo for $1.1B

Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to ...
Yahoo

Abbott raises profit forecast on strong medical device sales

(Reuters) -Abbott Laboratories raised its annual profit forecast on Thursday after its second-quarter earnings edged past Wall Street estimates on double-digit growth in sales of its glucose monitors ...
Medical Device Network on MSN

FDA approves Abbott’s Volt PFA system for atrial fibrillation

The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for ...
Crain's Chicago Business

Strong demand for Abbott's medical devices partially offsets COVID test declines

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. While Abbott Laboratories saw sales fall in the first ...
Seeking Alpha

Abbott Q3: Strong Growth In Medical Device And Pharma

I reiterate a “Strong Buy” rating for Abbott Laboratories with a fair value of $135 per share due to their strong R&D pipeline and robust financial performance. Abbott's recent results show 7.6% ...
Reuters

Abbott's strong medical device sales drive upbeat quarter as surgeries rebound

July 20 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Thursday beat quarterly profit expectations as a rebound in surgical procedure volumes drove demand for medical devices despite high ...
Star Tribune

Abbott reports strong medical device sales, topping profit expectations

Diversified health care company Abbott beat profit expectations for the first quarter with strong medical device sales and a rebounding baby formula business. Abbott reported adjusted earnings per ...
Forbes

Why Abbott Stock Looks More Attractive Than Its Medical Devices Peer

Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better pick than its peer Medtronic stock (NYSE: MDT). ABT stock trades at 4.9x trailing revenues, versus 3.6x for MDT. Although ...